Given the fact that inflammatory factors contribute to neuronal loss, synaptic loss, and behavior impairments in AD progression, we think that the TLR4-MYD88-NFκB-dependent anti-inflammatory effect of TLB might be accountable for its neuroprotective effect. This evidence concerns the gene NFKB1 and Alzheimer disease.